Stunning of neutrophils accounts for the anti-inflammatory effects of clodronate liposomes.

"Disclosures: The authors declare no competing interests exist."

"This work was supported by the Deutsche Forschungsgemeinschaft (FG 2886 “PANDORA” – B01/B02/A03/B04 to G. Krönke, F. Nimmerjahn, G. Schett, and M.H. Hoffmann, respectively, and the CRC1181-A03/A01/A02/A07/C03 Z2 to G. Krönke, G. Schett, F. Nimmerjahn, and M.H. Hoffmann), the Emerging Field Initiative of the Friedrich-Alexander University Erlangen-Nürnberg (EFI_Verbund_Med_05_MIRACLE to G. Krönke), the Bundesministerium für Bildung und Forschung (MASCARA to G. Krönke and G. Schett; MelAutim to G. Krönke), and the European Union (Horizon 2020 ERC-2014-StG 640087 – SOS and ERC-2020-CoG 101001866 – INSPIRE to G. Krönke; and ERC-2018-SyG nanoSCOPE and RTCure to G. Schett). This work was supported by grants R01AI165661 from the National Institutes of Health/National Institute of Allergy and Infectious Diseases, H2020-FET-OPEN-2018-2020 (no. 861878) from the European Commission to A. Hidalgo and M.H. Hoffmann, and HR17_00527 from Fundacion La Caixa to A. Hidalgo. The CNIC is supported by the Ministerio de Ciencia e Innovacion and the Pro-CNIC Foundation and is a Severo Ochoa Center of Excellence (MICINN award CEX2020-001041-S)."